A month has gone by since the last earnings report for Recursion Pharmaceuticals (RXRX). Shares have lost about 16.5% in that time frame, underperforming the S&P 500. Will the recent negative trend ...

SBS’s “No Tail to Tell” is racing towards its finish! On February 27, the fantasy romance drama—which has just one episode left in its run—enjoyed an increase in viewership ahead of its series finale.

A Wisconsin family has found a way to make their rescue dog, who lost her tail in harrowing circumstances, feel special. When Sydney the dog was found in a rural area just outside of Houston, Texas, ...

Shares of Recursion Pharmaceuticals (RXRX) spiked on Wednesday after the AI-driven drug developer significantly exceeded Street forecasts with its Q4 2025 financials, thanks primarily to a milestone ...

“Whoopsie daisy! Yoo-hoo!” Lana Del Rey is back, all right. The singer-songwriter has officially returned with “White Feather Hawk Tail Deer Hunter,” off her upcoming album, Stove. “White Feather Hawk ...

Recursion Pharmaceuticals' AI-based approach has the potential to transform the pharmaceutical industry. However, it is still chasing clinical wins that would demonstrate the power of its strategy.

When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...

We recently published 10 Big Names With Explosive Growth. Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of the best performers on Wednesday. Recursion Pharmaceuticals jumped by 16.44 percent on ...

Comet 3I/ATLAS is just the third observed interstellar object ever witnessed in Earth's solar system. The Gemini South telescope in Chile is the latest observatory to get a glimpse of the object as it ...